Validation of the Hospital Anxiety and Depression Scale in patients with decompensated cirrhosis.
作者信息
Zeng Chengbo, Donlan John, Indriolo Teresa, Li Lucinda, Zhu Enya, Zhou Joyce C, Armstrong Malia E, Pintro Kedie, Horick Nora, Chung Raymond T, Ei-Jawahri Areej, Edelen Maria O, Ufere Nneka N
机构信息
Patient Reported Outcomes, Value, and Experience (PROVE) Center, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
出版信息
Hepatol Commun. 2024 Nov 15;8(12). doi: 10.1097/HC9.0000000000000588. eCollection 2024 Dec 1.
Abstract
摘要
相似文献
1
Validation of the Hospital Anxiety and Depression Scale in patients with decompensated cirrhosis.医院焦虑抑郁量表在失代偿期肝硬化患者中的效度验证
Hepatol Commun. 2024 Nov 15;8(12). doi: 10.1097/HC9.0000000000000588. eCollection 2024 Dec 1.
2
Pre-hospital symptom clusters and symptom network analysis in decompensated cirrhotic patients: A cross-sectional study.失代偿期肝硬化患者院前症状群及症状网络分析：一项横断面研究。
J Adv Nurs. 2024 Jul;80(7):2785-2800. doi: 10.1111/jan.16044. Epub 2024 Jan 10.
3
Differences in anxiety among patients with liver cirrhosis with different compensation abilities.不同代偿能力肝硬化患者焦虑情绪的差异。
Am J Transl Res. 2022 Jul 15;14(7):5187-5194. eCollection 2022.
4
Psychological Distress Is Prevalent and Interdependent Among Patients With Decompensated Cirrhosis and Their Caregivers.
Am J Gastroenterol. 2025 Apr 1;120(4):909-913. doi: 10.14309/ajg.0000000000003158. Epub 2024 Oct 25.
5
Relieving effect of jiao-tune of 5-element music on negative emotions in patients with decompensated hepatitis B virus cirrhosis: A randomized and controlled experiment study.五行音乐角调对乙型肝炎肝硬化失代偿期患者负面情绪的缓解作用：一项随机对照实验研究。
Medicine (Baltimore). 2024 Sep 13;103(37):e39556. doi: 10.1097/MD.0000000000039556.
6
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.索磷布韦和维帕他韦联合或不联合利巴韦林治疗丙型肝炎病毒相关失代偿性肝硬化的患者报告结局：来自随机、开放标签 ASTRAL-4 期 3 期试验的探索性分析。
Lancet Gastroenterol Hepatol. 2016 Oct;1(2):122-132. doi: 10.1016/S2468-1253(16)30009-7. Epub 2016 Aug 3.
7
Construction and Application of Patient-Participated Health Care Guidance Plan for Patients with Decompensated Hepatitis B Cirrhosis.失代偿期乙型肝炎肝硬化患者参与式医疗指导方案的构建与应用
Hepat Med. 2024 Jun 4;16:45-54. doi: 10.2147/HMER.S455557. eCollection 2024.
8
Establishment and validation of a nomogram model for riskprediction of hepatic encephalopathy: a retrospective analysis.建立和验证肝性脑病风险预测的列线图模型：一项回顾性分析。
Sci Rep. 2023 Nov 9;13(1):19544. doi: 10.1038/s41598-023-47012-z.
9
The Impact of Cirrhosis on Outcomes of Patients Admitted With Diabetic Ketoacidosis: A Nationwide Study.肝硬化对糖尿病酮症酸中毒入院患者预后的影响：一项全国性研究。
Cureus. 2022 Jun 12;14(6):e25870. doi: 10.7759/cureus.25870. eCollection 2022 Jun.
10
Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia.印度尼西亚急性失代偿性肝硬化院内死亡率的预测评分系统。
BMC Gastroenterol. 2021 Oct 20;21(1):392. doi: 10.1186/s12876-021-01972-6.
引用本文的文献
1
Comparative Analysis of Patient-Reported Outcomes in Chronic Pruritus: Patients with Chronic Liver or Kidney Diseases Exhibit Higher Psychological Distress than Those with Atopic Dermatitis.慢性瘙痒患者自我报告结局的比较分析：慢性肝病或肾病患者比特应性皮炎患者表现出更高的心理困扰。
Dermatol Ther (Heidelb). 2025 Sep 11. doi: 10.1007/s13555-025-01539-3.
2
Self-efficacy-kinesiophobia correlation in postoperative patients with primary liver cancer: the chain-mediating effect of postoperative fatigue and negative emotions.原发性肝癌术后患者自我效能感与运动恐惧的相关性：术后疲劳和消极情绪的链式中介作用
Front Psychol. 2025 Aug 26;16:1597999. doi: 10.3389/fpsyg.2025.1597999. eCollection 2025.
3
Tides of emotion: Hepatologists' role in navigating depression and anxiety in liver disease.情绪的浪潮：肝病专家在应对肝病患者抑郁和焦虑方面的作用
Hepatol Commun. 2025 Jul 14;9(8). doi: 10.1097/HC9.0000000000000741. eCollection 2025 Aug 1.
本文引用的文献
1
The Edmonton Symptom Assessment System is a valid, reliable, and responsive tool to assess symptom burden in decompensated cirrhosis.埃德蒙顿症状评估系统是一种有效、可靠且敏感的工具，可用于评估失代偿性肝硬化患者的症状负担。
Hepatol Commun. 2024 Mar 18;8(4). doi: 10.1097/HC9.0000000000000385. eCollection 2024 Apr 1.
2
Palliative clinical trials in advanced chronic liver disease: Challenges and opportunities.晚期慢性肝病的姑息性临床试验：挑战与机遇
J Hepatol. 2023 Nov;79(5):1236-1253. doi: 10.1016/j.jhep.2023.06.018. Epub 2023 Jul 5.
3
COSMIN guideline for systematic reviews of patient-reported outcome measures.COSMIN 患者报告结局测量系统评价指南。
Qual Life Res. 2018 May;27(5):1147-1157. doi: 10.1007/s11136-018-1798-3. Epub 2018 Feb 12.
4
Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis.癌症和姑息治疗环境中医院焦虑和抑郁量表（HADS）的诊断有效性：荟萃分析。
J Affect Disord. 2010 Nov;126(3):335-48. doi: 10.1016/j.jad.2010.01.067. Epub 2010 Mar 5.
5
Prospective validation of the short form liver disease quality of life instrument.肝病生活质量简表的前瞻性验证
Aliment Pharmacol Ther. 2008 Nov 1;28(9):1088-101. doi: 10.1111/j.1365-2036.2008.03817.x. Epub 2008 Jul 30.
6
The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者医院焦虑抑郁量表的最小重要差异
Health Qual Life Outcomes. 2008 Jul 2;6:46. doi: 10.1186/1477-7525-6-46.
7
Monitoring depression treatment outcomes with the patient health questionnaire-9.使用患者健康问卷-9监测抑郁症治疗结果。
Med Care. 2004 Dec;42(12):1194-201. doi: 10.1097/00005650-200412000-00006.
8
The PHQ-9: validity of a brief depression severity measure.PHQ-9：一种简短抑郁严重程度测量工具的效度
J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
9
Individual-patient monitoring in clinical practice: are available health status surveys adequate?临床实践中的个体患者监测：现有的健康状况调查是否足够？
Qual Life Res. 1995 Aug;4(4):293-307. doi: 10.1007/BF01593882.
10
The hospital anxiety and depression scale.医院焦虑抑郁量表。
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
Zotero 插件